Autolus Therapeutics (AUTL) Leases (2019 - 2025)
Historic Leases for Autolus Therapeutics (AUTL) over the last 8 years, with Q3 2025 value amounting to $56.6 million.
- Autolus Therapeutics' Leases fell 640.96% to $56.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $56.6 million, marking a year-over-year decrease of 640.96%. This contributed to the annual value of $55.5 million for FY2024, which is 870.69% down from last year.
- Latest data reveals that Autolus Therapeutics reported Leases of $56.6 million as of Q3 2025, which was down 640.96% from $58.6 million recorded in Q2 2025.
- In the past 5 years, Autolus Therapeutics' Leases registered a high of $60.8 million during Q4 2023, and its lowest value of $1.8 million during Q2 2022.
- Over the past 5 years, Autolus Therapeutics' median Leases value was $54.3 million (recorded in 2023), while the average stood at $37.2 million.
- As far as peak fluctuations go, Autolus Therapeutics' Leases plummeted by 6364.04% in 2021, and later soared by 297545.35% in 2023.
- Quarter analysis of 5 years shows Autolus Therapeutics' Leases stood at $18.8 million in 2021, then increased by 23.62% to $23.2 million in 2022, then soared by 161.92% to $60.8 million in 2023, then fell by 8.71% to $55.5 million in 2024, then increased by 2.03% to $56.6 million in 2025.
- Its Leases stands at $56.6 million for Q3 2025, versus $58.6 million for Q2 2025 and $56.2 million for Q1 2025.